Who founded Shorla Oncology?

Shorla Oncology was founded by Sharon Cunningham, Orlaith Ryan in 2018.

Who are Shorla Oncology's investors?

Shorla Oncology's investors include Kurma Partners, Seroba Life Sciences, Enterprise Ireland.

How much funding has Shorla Oncology raised?

Shorla Oncology has disclosed $35M raised across 1 of its 3 known rounds.

Where is Shorla Oncology headquartered?

Shorla Oncology is headquartered in Dublin, IE.

Shorla Oncology

Dublin, IE · Founded 2018 · 35 employees on LinkedIn · 4 known investors

Find your way into Shorla Oncology

Paths you didn't know you had: your email and LinkedIn already hold routes to the Shorla Oncology team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Shorla Oncology develops pharmaceutical products to address unmet needs in oncology. The company was founded by healthcare entrepreneurs with extensive experience in the pharmaceutical industry and regulatory affairs.

Biotech Healthtech Medical Devices

Founders & leadership

Shorla Oncology was founded in 2018 by Sharon Cunningham and Orlaith Ryan.

Sharon Cunningham CEO & Co-FounderShe holds a Chartered Accountant qualification and an MBA from University College Dublin Michael Smurfit Graduate Business School, along with a BSc in Finance from University College Cork.

Orlaith Ryan CTO & Co-FounderCTO and co-founder of Shorla Oncology, a specialty pharmaceutical company developing oncology therapies. Ryan holds an MSc in Regulatory Affairs, is a Chartered Scientist, and serves as module leader for TOPRA's MSc program in Regulatory Affairs.

Investors · 4

Kurma Partnerslisted by Kurma PartnersParis · $162K – $10.8M

How we know: Kurma Partners's portfolio page · the VCSheet dataset · Not right? Tell us

Seroba Life Scienceslisted by Seroba Life SciencesDublin · $540K – $7.6M

How we know: funding news · shorlaoncology.com · Not right? Tell us

Enterprise IrelandreportedDublin · $800K

How we know: shorlaoncology.com · Not right? Tell us

Also in the syndicate · 1

Kurma Partners' Growth Opportunities Fundlead

Funding

SEC filings, press & company announcements

$35M disclosed across 1 of 3 rounds · 2023

$35MSeries BOct 2023 · 2 sources
Kurma Partners' Growth Opportunities Fund (lead), Enterprise Ireland, Seroba Life Sciences
Source ↗
Undisclosed amountSeries-BOct 2023
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Shorla Oncology raises $35m to accelerate growth - Shorla Oncology: A Leader in Innovative Oncology Solutionsshorlaoncology.com · Oct 2023

PRESS RELEASE: Shorla Oncology Secures $35M Series B Funding Round to Advance its Oncology Product Portfolio - Shorla Oncology: A Leader in Innovative Oncology Solutionsshorlaoncology.com · Oct 2023

Frequently asked questions

What does Shorla Oncology do?: Shorla Oncology develops pharmaceutical products to address unmet needs in oncology. The company was founded by healthcare entrepreneurs with extensive experience in the pharmaceutical industry and regulatory affairs.
Who founded Shorla Oncology?: Shorla Oncology was founded by Sharon Cunningham, Orlaith Ryan in 2018.
Who are Shorla Oncology's investors?: Shorla Oncology's investors include Kurma Partners, Seroba Life Sciences, Enterprise Ireland.
How much funding has Shorla Oncology raised?: Shorla Oncology has disclosed $35M raised across 1 of its 3 known rounds.
Where is Shorla Oncology headquartered?: Shorla Oncology is headquartered in Dublin, IE.